Showing results (2061-2070 of 3,154) with videos related to
Sort By:
Pageof 316
Journal of the European Academy of Dermatology and Venereology : JEADV|April 20, 2022
A topical emollient mitigates the progression of cognitive impairment in the elderly: a randomized, open-label pilot trialL Ye, Z Wang, Y Kim, et al.Stroke|November 5, 1999
Serial study of apparent diffusion coefficient and anisotropy in patients with acute strokeQ Yang, B M Tress, P A Barber, et al.Chemical & Pharmaceutical Bulletin|October 12, 1999
Total synthesis and chemical biology of the sarcodictyinsK C Nicolaou, J Pfefferkorn, J Xu, et al.Cancer Cell International|November 1, 2011
Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoterJessica T Li, Ka Bian, Alan L Zhang, et al.Optics Express|March 16, 2012
Hong-Ou-Mandel interference mediated by the magnetic plasmon waves in a three-dimensional optical metamaterialS M Wang, S Y Mu, C Zhu, et al.Clinical Nephrology|November 30, 2005
Chromosomal telomere shortening of kidney cells in IgA nephropathy by the measurement of DNA in urinary sedimentC C Szeto, P Y K Poon, F M M Lai, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 17, 2014
Increased bone resorption during tenofovir plus lopinavir/ritonavir therapy in Chinese individuals with HIVE Hsieh, L Fraenkel, W Xia, et al.Oncogene|October 24, 2017
MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesisS Li, X Liang, L Ma, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 18, 2020
Gender-specific SBNO2 and VPS13B as a potential driver of osteoporosis development in male ankylosing spondylitisT Li, W-B Liu, F-F Tian, et al.Cancer Research Communications|April 3, 2025
Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid TumorsDazhi Liu, Justin Jee, Alexander Drilon, et al.Pageof 316